<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR6">
 <label>6.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>d'Amore</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Gaulard</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Tr√ºmper</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Corradini</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>WS</given-names>
   </name>
   <name>
    <surname>Specht</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Bjerregaard Pedersen</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Ladeto</surname>
    <given-names>M</given-names>
   </name>
   <collab>on behalf of the ESMO Guidelines Committee</collab>
  </person-group>
  <article-title>Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</article-title>
  <source>Ann Oncol</source>
  <year>2015</year>
  <volume>26</volume>
  <issue>suppl 5</issue>
  <fpage>v108</fpage>
  <lpage>v115</lpage>
  <pub-id pub-id-type="doi">10.1093/annonc/mdv201</pub-id>
  <pub-id pub-id-type="pmid">26314772</pub-id>
 </element-citation>
</ref>
